Merck & Co., Inc. is 60.0x more valuable than Amneal Pharmaceuticals, Inc. by market capitalization ($293.16 B vs $4.89 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | AMRX | MRK |
|---|---|---|
| Market cap | $4.89 B | $293.16 B |
| US-listed rank | #1397 | #44 |
| Revenue (latest FY) | $3.02B | $65.01B |
| Net income (latest FY) | $72.06M | $18.25B |
| Net margin | 2.4% | 28.1% |
| P/E (trailing FY) | 67.8 | 16.1 |
| SEC filings | 664 | 996 |
Merck & Co., Inc. is 60.0x more valuable than Amneal Pharmaceuticals, Inc. by market capitalization ($293.16 B vs $4.89 B).
In their latest fiscal years, Amneal Pharmaceuticals, Inc. reported $3.02B in revenue while Merck & Co., Inc. reported $65.01B.
Full pages: Amneal Pharmaceuticals, Inc. and Merck & Co., Inc., or browse the full rankings.